← All sarcoma trials
Recruiting nowPhase 2Ages 18 Years and up

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Sponsor: Centre Oscar Lambret · NCT05500391 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Stage I Testicular SeminomaStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal TumorsOvarian Germ Cell TumorAdenocarcinoma, Clear CellBorderline Ovarian TumorSex Cord-Stromal TumorMucinous Adenocarcinoma of OvaryCarcinoma, Small CellCarcinosarcoma, OvarianSerous Tumor of OvaryGliomaNeuroendocrine TumorsAggressive Fibromatosis of Abdominal Wall (Disorder)

What it tests

  • Oncological Follow-upother

Where it's running3 sites

3 international sites

  • CHU Amiens

    Amiens, France 80054

    Opening soon
    • Guillaume BONNET(contact)[email protected]
    • Guillaume BONNET(principal investigator)
    • Mathieu BOONE, MD(sub investigator)

  • Centre François Baclesse

    Caen, France 14076

    Opening soon

  • Centre Oscar Lambret

    Lille, France 59020

    Recruiting now
    • Laurence ROTSAERT(contact)[email protected]
    • Laurence ROTSAERT(principal investigator)
    • Nicolas PENEL, MD(sub investigator)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Positive diagnosis (anatomopathology) of tumor within 12 months
* Patient 18 years of age or older
* Patient with one of the following conditions:

  1. Desmoid fibromatosis of the abdominal wall operated on or under active surveillance
  2. Stage I testicular seminoma (whether or not treated with carboplatin AUC7)
  3. Stage I non-seminomatous germ cell tumor (with or without adjuvant BEP chemotherapy)
  4. Operated GIST with low risk of relapse
  5. Rare gynecological tumors (sex cord and stromal tumors; germ cell tumors of the ovary, clear cell adenocarcinoma, mucinous adenocarcinoma of the ovary, borderline tumors, small cell carcinoma, ovarian and uterine carcinosarcoma, low grade serous tumors), operated
  6. Low-grade glioma, operated
  7. Low-grade neuroendocrine tumor, treated by surgery alone
* Patient who has given consent to participate in the study

Exclusion Criteria:

* Contraindication to imaging tests required for the surveillance plan
* No telephone
* Patient under guardianship or curatorship

Updated 2026-03-18 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.